LOGIN  |  REGISTER
Cue Biopharma
Compass Therapeutics

Oscar Health 2024 Fourth Quarter and Full Year Earnings Conference Call

January 09, 2025 | Last Trade: US$18.34 0.25 1.38

NEW YORK / Jan 09, 2025 / Business Wire / Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, will release its fourth quarter and full year 2024 financial results after the market closes on Tuesday, February 4, 2025.

Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows:

Live Call: 1.855.761.5600
Conference ID: 7768132
Webcast

The call will be archived and available on Oscar’s investor relations website (ir.hioscar.com) following February 4, 2025 for a period of 90 days.

About Oscar Health

Oscar Health, Inc. (“Oscar”) is a leading healthcare technology company built around a full stack technology platform and a relentless focus on serving our members. We have been challenging the status quo in the healthcare system since our founding in 2012, and are dedicated to making a healthier life accessible and affordable for all. Oscar offers Individual & Family plans and health technology solutions that power the healthcare industry through +Oscar. Our technology drives superior experiences, deep engagement, and high-value clinical care, earning us the trust of approximately 1.65 million members, as of September 30, 2024.

Viking Therapeutics

Stock Quote

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page